Literature DB >> 23021505

Prognosis of symptomatic patients with the A3243G mutation of mitochondrial DNA.

Chi-Hung Liu1, Chien-Hung Chang, Hung-Chou Kuo, Long-Sun Ro, Chia-Wei Liou, Yau-Huei Wei, Chin-Chang Huang.   

Abstract

BACKGROUND/
PURPOSE: The clinical analyses and prognoses of mitochondrial diseases with A3243G mutation are rarely documented in Taiwan. Our study investigated the clinical phenotypes and the outcomes of patients with mitochondrial disease and the A3243G mutation of mtDNA in a Taiwanese population, and compared these with previous reports.
METHODS: We retrospectively studied 22 consecutive patients with mitochondrial disease and the A3243G mutation of mtDNA in Chang Gung Memorial Hospital between 1988 and 2009. All patients underwent a detailed demographic registration, neurological examinations, a muscle biopsy, and mitochondrial DNA analysis. Modified Rankin scale, the presence of recurrent strokes or seizures, critical medical complications, and death were monitored during the follow-up period.
RESULTS: Of the 22 patients, seizures and stroke-like episodes were found in 12 (55%). Visceral involvement, including cardiomyopathy, nephropathy, and pulmonary hypertension, were noted in five patients (23%). Patients with seizures had a high frequency of status epilepticus (92%) and a younger age of onset (21.3±7.2 years). Both the Kaplan-Meier survival analysis and the Cox-regression model showed a marked deterioration in patients with seizures after 7 years of follow-up.
CONCLUSION: Our study found that seizures and status epilepticus are the most important predictive values for a poor outcome in patients with the mtA3243G mutation of mtDNA. Age of onset and visceral organ involvement had no prominent influence on the prognosis. Some medical complications could be well controlled or even reversed after management.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021505     DOI: 10.1016/j.jfma.2011.06.014

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  9 in total

1.  Mitochondrial genetic analysis in a Chinese family suffering from both mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes and diabetes.

Authors:  Weiwei Li; Wei Zhang; Fang Li; Cailing Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Mitochondrial DNA mutations and cardiovascular disease.

Authors:  Alexander W Bray; Scott W Ballinger
Journal:  Curr Opin Cardiol       Date:  2017-05       Impact factor: 2.161

3.  Intra-patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation.

Authors:  Paul de Laat; Richard J Rodenburg; Jan A M Smeitink; Mirian C H Janssen
Journal:  Mol Genet Genomic Med       Date:  2018-12-04       Impact factor: 2.183

4.  Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature.

Authors:  Paul de Laat; Nienke van Engelen; Jack F Wetzels; Jan A M Smeitink; Mirian C H Janssen
Journal:  Clin Kidney J       Date:  2019-04-21

5.  Maternally inherited coronary heart disease is associated with a novel mitochondrial tRNA mutation.

Authors:  Zhenxiao Zhang; Mingyang Liu; Jianshuai He; Xiaotian Zhang; Yuehua Chen; Hui Li
Journal:  BMC Cardiovasc Disord       Date:  2019-12-16       Impact factor: 2.298

6.  Long-Term Progression and Rapid Decline in Hearing Loss in Patients with a Point Mutation at Nucleotide 3243 of the Mitochondrial DNA.

Authors:  Aki Sakata; Akinori Kashio; Hajime Koyama; Tsukasa Uranaka; Shinichi Iwasaki; Chisato Fujimoto; Makoto Kinoshita; Tatsuya Yamasoba
Journal:  Life (Basel)       Date:  2022-04-06

7.  Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.

Authors:  Alejandro Horga; Robert D S Pitceathly; Julian C Blake; Catherine E Woodward; Pedro Zapater; Carl Fratter; Ese E Mudanohwo; Gordon T Plant; Henry Houlden; Mary G Sweeney; Michael G Hanna; Mary M Reilly
Journal:  Brain       Date:  2014-10-03       Impact factor: 13.501

Review 8.  The aetiology of cardiovascular disease: a role for mitochondrial DNA?

Authors:  Marianne Venter; Francois H van der Westhuizen; Joanna L Elson
Journal:  Cardiovasc J Afr       Date:  2017-08-25       Impact factor: 1.167

Review 9.  The Role of Mitochondrial DNA Mutations in Cardiovascular Diseases.

Authors:  Siarhei A Dabravolski; Victoria A Khotina; Vasily N Sukhorukov; Vladislav A Kalmykov; Liudmila M Mikhaleva; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.